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In discussions of eczema, brief mention is usually made of the
fact that superimposed infection often complicates the disease, but
one does not gather that the secondary malady is regarded as a
factor which may be of prime importance in determining the clinical
pattern of the sickness. The parasites may be viruses, fungi, or
bacteria and the infection may be single or multiple in etiology.
Examples of grave virus infection in cases of eczema are seen in
certain patients with generalized vaccinia and in those with the
"pox-like" disease associated with eczema recently described from
this Clinic by Wenner;18 in both circumstances, the secondary disease
is more serious than is the primary.
An example of serious bacterial infection of eczema is furnished
by hemolytic streptococcal disease associated with atopic dermatitis.
The importance of this condition came to light in the course of
studies on streptococcosis" 2, 13 which have developed in this Depart-
ment under the stimulus -of Dr. Trask. In the various clinical
patterns of hemolytic streptococcal disease in children, lesions of the
skin and its appendages are important-erysipelas, cellulitis, pyo-
dermia, ecthyma, paronychia, and some cases of impetigo contagiosa
and pemphigus neonatorum. In Table 1 may be found data on
the relative incidence of certain skin infections due to the hemolytic
streptococcus as observed on the Pediatric Service (in-patients) of
the New Haven Hospital during a period of six years-three years
before the introduction of the sulfonamides and three years there-
after. The patients who had streptococcal dermatitis of whatever
type often, indeed usually, suffered from streptococcal fever, and
rhinopharyngeal cultures were positive for the hemolytic strepto-
* From the Department of Pediatrics, Yale University School of Medicine, and
the Children's Clinic, New Haven Hospital. Aided by a grant from the Fluid
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TABLE 1
INCIDENCE OF ACTIVE STREPTOCOCCOSIS, IN-PATIENT SERVICE,
CHILDREN S CLINIC,* NEW HAVEN HOSPITAL
Group 1 (3 years) Group II (3 years)
Diagnosis before sulfonamides after sulfonamides
Streptococcal fever ................................................
Tonsillitis ............................................................
Laryngitis ............................................................
Scarlet fever ........................................................
Surgical scarlet fever ............................................
Bacteremia ............................................................
Suppurative cervical adenitis ................................
Suppurative otitis media ......................................
Mastoiditis ..........................................................
Sinus thrombosis ..................................................
Brain abscess ........................................................
Meningitis ............................................................
Retropharyngeal abscess ........................................
Peritonsillar abscess ..............................................
Suppurative axillary adenitis ................................
Suppurative inguinal adenitis ................................
Empyema ............................................................
Sinusitis ................................................................
Pericarditis ..........................................................
Peritonitis ............................................................
Osteomyelitis .......................................................
Suppurative arthropathy ........................................
Purulent conjunctivitis ........................................
Panophthalmitis ....................................................
Pyuria ..................................................................
Vaginitis ..............................................................
Erysipelas ............................................................
Pyodermia (including eczema and cellulitis).
Paronychia ............................................................
29
24
4
38
5
36
23
49
26
1
1
10
11
8
5
0
8
1
1
5
4
1
1
0
1
0
25
15
2
106
47
4
111
6
14
21
65
8
1
3
3
1
4
4
1
7
1
1
0
0
1
I
1
2
5
15
28
.3
* Patients under 16 years of age; cases primarily surgical on admission are not
included. The age distribution of all admissions to the Service is illustrated by the
record for 1941 to which that of other years is similar:
No. % No. % No. %
Sick newborns 42 4.4 5 yrs .... 47 4.9 11 yrs .... 36 3.8
Newborn to 1 yr. 186 19.5 6 yrs .... 42 4.4 12 yrs .... 37 3.9
1 yr. to 2 yrs 106 11.1 7 yrs .... 46 4.8 13 yrs .... 27 2.8
2 yrs .95 9.9 8 yrs. .... 51 5.3 14 yrs .... 31 3.2
3 yrs .......... 70 7.3 9 yrs .... 31 .3.2 15 yrs .... 23 2.4
4 yrs .......... 59, 6.2 10 yrs .... 27 2.8
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coccus; skin lesions often very directly followed contamination of
the fingers from the mouth.*
In a six-year period, 1938-1943 inclusive,t 203 patients with
eczema were treated in the pediatric out-patient service of the New
Haven Hospital, eczema accounting for approximately one per cent
of the total admissions. Sixty-four of these 203 (about 30 per cent)
presented clinical evidence of infection at some time during the
period of observation. The total number of infections was 103 since
some patients became infected several times. One child was infected
eight times over a five-year period; on at least two occasions, infec-
tion was by hemolytic streptococci as demonstrated by cultures from
the lesions. Children treated in the out-patient service are not
included in the general discussion which follows in this paper unless
they were admitted to the hospital wards. Dispensary patients were
not followed regularly and carefully enough to be of value in this
study. However, the skin was cultured in 39 instances of infection
and hemolytic streptococci were recovered from 26 (66 per cent).
From this small series, it would appear that hemolytic streptococci
are associated with infected eczema in about two-thirds of the cases;
it is of interest that these organisms were recovered from 17 of 21
patients hospitalized from the dispensary (81 per cent); such hos-
pitalization was without knowledge of the skin cultures at the time.
In general, it may be said that the child requiring hospitalization for
the treatment of eczema is likely to be under three years of age and
the skin lesions are usually infected with hemolytic streptococci;
* Recently, cultures were taken from the fingers of 60 infants and children who
were under treatment in the dispensary and wards of the New Haven Hospital for
a variety of illnesses. Hemolytic streptococci were recovered from 6 and pneu-
mococci from 2. Staphylococci were present on the fingers in varying numbers
in all cultures. The frequency with which hemolytic streptococci were demon-
strated may be misleading unless the presenting illnesses of these patients are con-
sidered. Five had clinical streptococcal infection of the upper respiratory tract
including one case of scarlet fever. The presenting illness of the sixth child was
"impetigo" of the face. He had a recent sore throat with fever. All children had
hemolytic streptococci in cultures of the fingers and rhinopharynx and these organ-
isms belong in Group A. In the case of the sixth child the organisms were also
recovered from the skin lesion. For each patient streptococci from all sources were
identical as to serological type.
t The three post-sulfonamide years of the study summarized in Table 1 plus the
next three years are the ones under consideration here.YALE JOURNAL OF BIOLOGY AND MEDICINE
some admissions for eczema, of course, are dictated by social rather
than medical requirements.
In Table 2 is shown the incidence of eczema cases on the in-
patient Pediatric Service of the New Haven Hospital for six years,
1938-1943 inclusive; there were 76 such admissions. The present
study is based on data available in the records of these patients and
is admittedly very inadequate because the prime importance of
infection in eczema in children has been appreciated only gradually
and a careful investigation of the subject was never really planned.
Therefore, this report must be regarded as an orientation procedure,
designed to call attention to a condition that is recognized but is not
adequately stressed, and to stimulate a carefully planned investiga-
tion of the subject.
TABLE 2
IN-PATIENT ADMISSIONS FOR ECZEMA
1938. 8 1941 ................ 16
1939. 5 1942 ................ 18
1940 . 11 1943 ................ 18
Total: 76 Admissions; 68 Individuals
Patients No. of Admissions Total Admissions
61 1 61
6 2 12
1 3 3
68 76
A list of patients was prepared showing their age at the time of
each of the 76 admissions. The tabulation revealed in our series
the well-known fact that atopic dermatitis is most frequently seen
in children under two years of age (64 per cent, this series). There
was a fair number of cases during the next three years of life but
during the ensuing years the incidence of eczema admissions became
low. The age period when eczema is most common is the same as
that when the childhood type of streptococcal fever is most fre-
quently seen.
Another listing of cases setting forth the admissions for eczema
by months showed that the patients entered the hospital in each
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month ofthe year but the greatest numberwas in the spring months;
there is a parallelism here between eczema admissions and those for
streptococcal disease.2
A diagnosis of infected eczema was made in the first instance on
many of the cases in this series on clinical grounds. The diagnosis
was not always supported by data from cultures. Staphylococci are
often cultured from normal skin and when present in cases of eczema
their rOle is difficult to appraise beyond observation as to their pres-
ence in abscesses or in the blood; there were no such occurrences in
this series. Bacteriological study of the staphylococci isolated from
cases of clinically infected eczema generally included their ability to
ferment mannite and coagulate plasma-tests for pathogenicity.
These tests were usually performed when staphylococci alone were
present in cultures of the skin; when hemolytic streptococci were
simultaneously recovered, the staphylococci were often simply iden-
tified by colony-appearance and stained smear. Hemolytic strepto-
cocci in most instances out-numbered the staphylococci. This is
another reason why we place greater emphasis on the hemolytic
streptococcus as the primary offending organism.
Concerning the incidence of hemolytic streptococci in general, it
is germane to recall, that Colebrook, Maxted, and Johns cultivated
organisms belonging to Group A from the "hands of 7 out of, 181
normal individuals (3.8 per cent)."5 However, it would seem that
this bacterium is rarely present in individuals not suffering from or
recently convalescent from some form of streptococcal fever; this
seems to be true so far as infants and young children are concerned.
In the study upon which Table 1 is based, it was demonstrated that
in our hospital cases of the period, 15 per cent of the patients had
active streptococcosis and 10 per cent were carriers of hemolytic
streptococci in the rhinopharynx even when active streptococcosis was
not diagnosed. Boisvert"3 found a carrier rate of 7 per cent for
Group A hemolytic streptococci; the subjects from whom rhino-
pharyngeal cultures were taken were 190 members of 30 families
in each of which at least one member had pertussis.
In our series of eczema patients, 48 of the 76 (re-admissions
considered as new patients), showed clinical evidence of infection as
well as of eczema of the skin (Table 3). There is no record of
skin cultures on three ofthese patients but some of the bacteriological
data concerning the 45 patients whose skin was cultured are shown
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in Table 3. Hemolytic streptococci were demonstrated in 36 cases
(80 per cent) and they were the only organisms demonstrated in
cultures from 7 patients (15 per cent); staphylococci were the only
organisms demonstrated in 9 patients (20 per cent). In four
TABLE 3
RESULTS OF CULTURES
Positive cultures for
Strep. hemolyticus
Eczema Skin cultures Number Blood Rhinopharyngeal
H. Strep. 7 0 4
Clinically H. Strep.
infected and Staph.* 29 3 24
(48) Staph.* 9 0 2
Not cultured 3 1 2
H. Strep.
and Staph.t I 0 0
Staph. 9 0 0
Clinically Staph. and
non-infected Diphtheroids 1 0 1
(28)
Staph. and
green Strep. 1 0 0
Not cultured 16 0 4
Total 76
* Two virus cases included in this group.
t Hemolytic streptococci, Group G.
patients, as indicated in the table, there was present, in addition, a
lesion which went through the stages of papule, vesicle, pustule, and
crust and from which a herpes simplex-like virus was demonstrated
byWenner;`8 one of these patients died within six days of admission.
Of the 36 patients whose skin cultures showed hemolytic strep-
tococci, 28 (77 per cent) also carried that organism in the rhino-ECZEMA AND HEMOLYTIC STREPTOCOCCAL DISEASE
pharynx as demonstrated in cultures. In 12 patients whose skin
was either not cultured (3) or the cultures showed no hemolytic
streptococci (9), this organism was found in cultures from the upper
respiratory tract in four (33 per cent) and, also, in the blood of one
of these. Thus, taking all of the cases of clinically infected eczema
(48) into consideration, whether or not hemolytic streptococci were
demonstrated on the skin, that parasite was found in the upper
respiratory tract of 32 (66 per cent of the total); by contrast, the
hemolytic streptococcus was demonstrated in the rhinopharynx of
only five (17 per cent) of the 28 patients whose eczema was not
clinically infected. Most regrettably, no cultures of the skin of 16
of these 28 patients were taken. This suggests that hemolytic strep-
tococci may well have been present on the skin in a fair percentage
of the twelve infected cases in whom cultures either were not taken
or showed only staphylococci.
Blood cultures were positive for hemolytic streptococci* in three
of the 36 infants with clinically infected eczema and having skin
cultures positive for that organism; there were four positive cultures
from these three patients. In a fourth infant, whose eczema was
obviously infected, cultures of the nose, throat, aural discharges,
and blood were positive for hemolytic streptococci, but skin cultures
were not taken. All patients having positive blood cultures were
infants (ages 6 mos., 8 mos., 1X2 years, and 2 years, respectively).
In Table 4 are shown such data as are available in this series
concerning the Lancefield groups of hemolytic streptococci8' 10, 14
from cultures of patients with eczema. The data are indeed meager;
Group A organisms, the usual human pathogens, were cultivated
from the skin in only 13 patients; in 20 cases in which no grouping
was carried out Group A may or may not have been well repre-
sented. In the proved Group A and C cases, the parallelism between
rhinopharyngeal and skin cultures is close. In seven instances the
serological types of the Group A strains were determined. For each
patient, organisms from the rhinopharynx and skin were identical
as to type. This suggests that eczema in a child who has strepto-
coccal fever or who is a carrier of hemolytic streptococci is likely to
become infected. This relationship also holds for other skin con-
ditions in children. Higgins,7 in a thesis prepared in this Clinic,
* Of the seven infants whose skin, nose, and throat cultures showed a growth of
staphylococci only, none had positive blood cultures.
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showed that of 71 cases of skin diseases (impetigo, eczema, post-
auricular intertrigo, epidermophytoses, vaccinia, etc.) 62 showed
hemolytic streptococci, Group A, in skin cultures and of these 20
per cent were proven to have that organism in the upper respiratory
tract; there was one Group C hemolytic streptococcus invader in
Higgins' series.
TABLE 4
CLASSIFICATION OF HEMOLYTIC STREPTOCOCCI FROM CULTURES
Clinically infected eczema
Skin and Rhinopharyngeal Cultures (Both positive) ............... .......................... 28
Group A in skin and in rhinopharyngeal cultures .................. ............ 7
Group A in skin cultures (rhinopharyngeal organisms not grouped) 4
Group A in rhinopharyngeal culture (skin organisms not grouped) 1
Group C in skin and in rhinopharyngeal cultures .................. ............ 2
Group C in rhinopharyngeal culture (skin organisms not grouped).. I
Skin and rhinopharyngeal culture organisms not grouped .................. 13
Skin Cultures (Rhinopharyngeal Cultures Negative) ...................... . 8
Group A in skin cultures ........................ 2
Group C in skin culture ........................ I
Skin culture organisms not grouped ........ ................ 5
Rhinopharyngeal Cultures (Skin Cultures Negative) ...................... . 2
Group A in rhinopharyngeal culture . .................................. 1
Rhinopharyngeal culture organisms not grouped .............................. 1
Clinically non-infected eczema
Group G in skin culture (rhinopharyngeal culture negative) .................. 1
Clinical differentiation of those cases of eczema where there is
no hemolytic streptococcal infection from those cases where this com-
plication exists is based on no very clear-cut distinctions; only cul-
tures offer accurate diagnostic data. When the eczema is infected,
there may be fever and toxemia of greater degree than one expects
in uncomplicated cases. In infected patients who are hospitalized,
especially the infants, most of the body is involved in an inflamma-
tory process with marked erythema, induration, sero-sanguineous
exudation, crusting; all of these characteristics may be present in
apparently uninfected patients but not so regularly nor to the same
high degree. We would emphasize weeping as perhaps the most
important single differential characteristic suggesting that an eczema
is infected. Similarly, there is some general glandular enlargement
in almost all cases of eczema but the adenopathy is most marked
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when infection is present. Intense itching characterizes all cases of
eczema regardless of infection which is, of course, favored thereby,
particularly from fingers which have been contaminated from the
mouth. As already pointed out, a hemolytic streptococcal bac-
teremia is occasionally present, as is suppuration. Of course, in
respect to the latter condition the staphylococcus may be the offend-
ing organism. Regardless of infection, a leukocytosis and an eosino-
philia are often present in patients with eczema and are of little
differential assistance.
Fia. 1. Patient B. D., aged 3 mos. Eczema infected with hemolytic streptmocci.
A fairly typical example (Fig. 1) of infantile eczema with infec-
ti,on with hemolytic streptococci is as follows:
B. D., female, three months, was admitted to the New Haven Hospital on
December 14 1942. Eczema first appeared on the cheeks at one month of
age and progressed steadily to become generalized. Two weeks before admis-
sion goat's milk was substituted for cow's milk and there was considerable
improvement. Three days before admission the eczema became much worse,
and on the day of admission the baby had fever and was irritable. Hospitali-
zation was advised by the family physician.
The temperature on admission was 1010 F. The baby appeared moder-
ately ill and was scratching continuously. The scalp, cheeks, chin, and neck
were covered with yellowish-brown crusted and weeping lesions. The
shoulders, wrists, and the antecubital and popliteal spaces were roughened andYALE JOURNAL OF BIOLOGY AND MEDICINE
red. The occipital and posterior cervical lymph nodes were visibly enlarged.
There was no evidence of an upper respiratory infection.
Cultures of the nose, throat, and skin lesions yielded hemolytic strepto-
cocci. The organisms from both the rhinopharynx and skin were identified
as of a Group A, type 11 strain (one of the serological types prevalent in
New Haven at the time). Admission blood culture was sterile.
The baby was restrained, placed on cellophane, and sedated with pheno-
barbital to relieve the itching. Diet consisted of goat's milk with added
vitamins. Five per cent sulfathiazole ointment in white vaseline was applied
to the skin lesions every four hours for seven days. The temperature fell to
normal limits on the sixth hospital day. The skin lesions improved and the
adenopathy decreased, but a large furuncle on the scalp persisted. A repeat
skin culture on the tenth hospital day was negative for hemolytic streptococci.
Sulfathiazole ointment was replaced by a crude coal tar ointment with con-
tinued improvement in the eczema. Sulfathiazole was administered by
mouth and the furuncle subsided without suppuration. The baby was dis-
charged on the twenty-eighth hospital day to be followed in the pediatric
allergy clinic.
Table 4 shows that there were four cases in the present series in
which the organism isolated from the skin was a Group C hemolytic
streptococcus.8 10,14 One of these patients-an infant of eight
months-was gravely ill; not only was there extensive eczema which
appeared infected but also on face and neck there was a "pox-like"
lesion (previously referred to) from which Dr. Wenner18 isolated
a herpes simplex-like virus; the patient was hospitalized for 38 days.
A second infant in this category, a boy aged 4 months, was gravely
ill with pharyngitis, adenitis, and extensive weeping eczema. The
fever showed frequent spikes to 390 C. or 400 C. and there was a
leukocytosis of 29,300 and an eosinophilia of 15 per cent. The
patient was hospitalized 53 days; the skin was clear on discharge.
The third Group C patient, also an infant, had a simple mastoid-
ectomy at which cultures were not taken; the fourth case was that
of a 15-year-old girl whose scalp and ears were a mass of weeping,
excoriated, and crusted areas superimposed on a chronic eczematous
base. Group C organisms are usually not regarded as important
human pathogens; this is not invariably the case. It would appear
to us that they were acting as pathogens in these four patients.
The patient from whom a Group G hemolytic streptococcus was
isolated from the skin was a girl of 16 months. The eczema was
dry, most marked in the antecubital and popliteal spaces and on the
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wrists. There was a degree (centigrade) of fever for one week of
a three-week period of hospitalization. The white blood count was
22,000; eosinophiles 5 per cent. Group G hemolytic streptococci
are not considered to be human pathogens, although rare exceptions
have been reported. In this instance, their rOle as pathogens is
indeed debatable. The low-grade fever and leukocytosis suggest
infection but the appearance of the skin belied the presence of
infected eczema.
The treatment of children with eczema in this clinic is that gen-
erally carried out elsewhere. For small children, restraint to pre-
vent scratching is practiced and sedatives may be employed to the
same purpose; when there is moisture, exposure to heat under an
electric light cradle is regarded with favor; ointments prescribed
usually contain some coal tar derivative; foods have been mixtures
based on dried half-skimmed cow's milk, goat's milk, or soy-bean
or partially digested casein prepared foods-all with vitamin sup-
plements, in purified form as far as possible. In older children,
attempt is made to determine possible allergens and to control envi-
ronment accordingly.
As it became clear that many cases of eczema were also cases of
streptococcal disease and that the skin was frequently contaminated
with hemolytic streptococci, the use of sulfonamides orally and
externally in soaks and ointments in treatment was tried. Only ten
of the 48 patients with infected eczema in this series did not receive
sulfonamide therapy and 38 were so treated by one method or
another regardless of bacterial etiology. Table 5 refers only to 34
hemolytic streptococcal infected eczema cases of which 26 received
sulfonamide therapy. Methodology was experimental; various
sulfonamides were tried orally and externally and in combination.
Applications to the skin varied as to base for administration, as to
concentration, and as to the special sulfonamide to be selected.
Data concerning sulfonamide treatment of 34 patients whose
eczemawas infectedwith hemolytic streptococci are shown inTable 5.
Twelve patients (B) were treated orally and externally; five (C)
orally only; and nine (D) externally only. Eight patients (A)
were not treated with sulfonamides.
Since our interest in infection of the skin of eczematous children
stemmed directly from studies on streptococcosis,2 early experiments
in treatment began with the exhibition of sulfonamides both locally
and orally for streptococcal skin diseases. So far as infected eczema
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TABLE S
SULFONAMIDE TREATMENT OF ECZEMA INFECTED WITH HEMOLYTIC STREPTOCOCCI
(34. cases*)
A. Patients not treated with sulfonamides ...................................................... 8
Average no. days in hospital ............................................................ 19
B. External and oral treatment ............................................... ............. 12
Average no. days in hospital ............................................................ 30
Average no. days external treatment ...................................................... 15
Average no. days oral treatment ............................................................ 8
Several blood levels, all less than 4 mg. per cent
C. Oral treatment only .5
Average no. days in hospital. 37
Average no. days of treatment .9
Blood levels of drug, less than 4 mg. per cent
D. External treatment only ......................................... ....................... 9
Average no. days in hospital ............................................................ 15
Average no. days of treatment ............................................................ 12
Blood level of drug, two cases, less than 4 mg. per cent
Average no. of days in hospital of 28 patients with uncomplicated eczema was 23.
*Two exceptional cases, totalling three admissions, not included:
Hemolytic streptococcal (Group A) and viral infected eczema-1 case.
Hemolytic streptococcal (Group C) and viral infected eczema-i case.
itself is concerned, there appears to be no support in dinical experi-
ence for oral administration of sulfonamides. A level in the skin
of approximately one-half that present in the blood is obtained. A
much higher concentration of drug can be obtained locally by topical
application."5 If there is bacteremia, meningitis, pneumonia, ery-
sipelas, purulent otitis media, mastoiditis, or suppurative adenopathy
of streptococcal etiology, in a patient with infected eczema, oral
administration of sulfonamides is indicated. However, the usual
form of streptococcal disease associated with infected eczema is that
which we have called "streptococcal fever"-pharyngitis, cervical
adenopathy, and fever lasting usually for six weeks;2 it is a malady
influenced by sulfonamides in a very disappointing measure. In
these cases, constituting the great majority of our series, we have
come to rely on the local application of an ointment of five per cent
sulfathiazole in white vaseline;9 11 15 the lesions are kept greased;
no definite number of applications is prescribed.
The value of this treatment rests on clinical appraisal of the total
situation. Our good results in the dispensary patients (to whom no
606ECZEMA AND HEMOLYTIC STREPTOCOCCAL DISEASE
sulfonamides were administered orally) and our eventual apprecia-
tion that sulfonamides were of doubtful value in treating strepto-
coccal fever led us to the belief that our favorable results were due
largely to local applications. Under this regime, the value of the
sulfonamides is indicated by general systemic improvement, by low-
ering the fever, by a clearing of exudation and crusting, and by
eventual reduction in adenopathy. The children treated solely by
local applications of sulfonamides remained in the hospital for a
shorter period than did those treated orally with and without oint-
ment, but their course in respect to time was conditioned by other
circumstances, such as the presence or absence of the more serious
complications referred to in the previous paragraph. At any rate,
any appreciable reduction in hospitalization as a rule would not seem
likely, forthe infection is engrafted upon a chronic dermatitis. Once
in an institution, the child is kept on for treatment of the latter
malady although the strictly streptococcal aspect may have shown
amelioration; the line of demarcation between the two is usually
not clear. The physician is treating two diseases etiologically dif-
ferent but clinically fused; healing of the infection is ameliorative
but not curative of the eczema. And, further, the infection although
not chronic, tends to recur because it is usually a part of streptococcal
fever, a sub-chroni'c ailment.
Table 5 does not furnish adequate data for a discussion of sulfon-
amide blood concentrations in our series. One reason for the paucity
of our observations is found in one's hesitation to draw blood when
inflammation of the skin over the whole body exists. All levels
obtained were under four milligrams per cent with the exception of
two cases mentioned in the footnote to Table 5, in which the highest
readings were 7.3 and 16.7 mg. per cent, respectively. We used
sulfanilamide, sulfapyridine, sulfathiazole, and sulfadiazine in one-
half to ten per cent concentrations in ointments and soaks; as stated,
the application most frequently used was five per cent sulfathiazole
ointment; it might be wise to use a two per cent ointment in very
extensive lesions in which there is much broken skin. On this point,
Cole4 comments thus:
Apparently in using sulfonamide compounds on the skin the amount of
absorption, if any, will depend on its concentration in the medicament, on the
condition of the skin, intact or broken, on the drug itself (thus sulfathiazole
is absorbed less than sulfanilamide) and on the type of base. If one is work-
ing with sulfonamides in glycerin there will be far more absorption than from
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an ointment base or even from an oil in water base. Apparently, however,
in practically no case in which sulfathiazole has been used will there be
appreciable absorption into the blood stream.
Our favorable regard for a five per cent sulfathiazole ointment
having petrolatum alba for its base raises the question of a greasy
medicament. We have no data upon which to enter a debate-
only the fact that in most cases this ointment seemed to give very
satisfactory results.16 In his review on chemotherapy in dermatol-
ogy, Cole4 states
that greasy bases are unsatisfactory for applying sulfonamides locally. A
grease will seal off the area, it does not mix with serum, and it may coat
over the underlying infection and furnish an anaerobic pocket in which infec-
tion may thrive. Moreover, bacteria covered -with a film of grease will not
be so easily reached by the medicament. Oil in water emulsion bases provide
a more satisfactory medium than vanishing cream compounds and are appar-
ently the best bases for applying any of the sulfonamides.
We cannot state to what degree eczematous skin as a carrier of
hemolytic streptococci was influenced by sulfonamide ointments;
our data establish only the fact of clinical improvement and that in
many cases cultures became negative before the patient was dis-
charged. We know that re-infections seem to have taken place in
certain patients.
Our data on infection of the skin with hemolytic streptococci of
Group C are too meager to merit conclusions as to the influence of
sulfonamide treatment.
The question of sensitization reactions3' 6, 12, 17 to sulfonamides is
one of great importance in the subject presented here. If, for
example, a relatively benign post-auricular intertrigo infected with
hemolytic streptococci is cured with topical application of five per
cent sulfathiazole ointment only to have the patient become hyper-
sensitive so that the drug cannot be given on a subsequent occasion
when he may be seriously ill with meningitis, then the price for the
original success is much too high. We quote Cole4 again as follows:
In the light of present data sulfonamides should not be administered locally
for more than five days because of the danger of sensitizing the individual
and perhaps later precluding internal sulfonamide therapy where the situation
may involve a far graver disease, e.g. a pneumonia or a bacteremia.
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In our series, certainly the average period over which the drug
was administered was nearer ten than five days; although two
patients developed fever as a toxic effect of the drug, no case of
sensitization in the sense of a re-administration phenomenon
occurred. Four patients received sulfonamides during two hospital
admissions and a fifth child on four separate occasions without toxic
reaction. Eight of the twelve admissions were for infected eczema,
two for pneumococcal pneumonia, and two for extensive burns which
were infected. One must recall that a vast number of persons have
received sulfonamides for very minor illnesses. Infants because of
their youth are perhaps somewhat less likely to have received sul-
fonamides, particularly in repeated courses. For this reason-and
probably others-patients with infantile eczema may not show the
sensitization phenomenon so readily as older children and adults.
Lyons and Balberor state that 36 per cent of their patients (adults)
experienced febrile reactions when sulfathiazole was administered
although such reactions occurred in only five per cent of their cases
in which a single course of the drug was given. Green, Steckel and
Michener were unable to confirm these observations. In our opin-
ion, the physician will have to make the decision in any given case
of eczema infected with hemolytic streptococci as to whether almost
certain improvement with sulfonamide ointment should be achieved
at the risk of possible toxic or sensitization effects.
Sulfonamide treatment of infantile eczema infected with hemo-
lytic streptococci may be superseded by other medicaments such as
penicillin. Reports on very limited observations indicate favorable
developments in penicillin therapy in this field.
In the two exceptional cases of combined streptococcal and viral
infection of eczema (footnote to Table 5) the use of sulfathiazole
ointment seemed definitely harmful with respect to the herpetic
lesions; they spread and became confluent and indurated.
Summnary and conclusions
From a survey of the material presented in this paper it is obvious
that any consideration of infantile eczema must take into account the
likelihood that, in a large number of the severe cases, the skin lesions
areinfedted with hemolytic streptococci; the statement is true for
New Haven and probably also for other communities where strep-
tococcosis is common.
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Furthermore, the course of the patient's illness is significantly
altered by the streptococcal infection-there is more fever, prostra-
tion, irritability, local exudation, and adenopathy than in uncom-
plicated eczema; bacteremia may be present in a not inconsiderable
number of patients.
Certain other facts deserve emphasis.
1. Atopic dermatitis-and streptococcal fever-rhinopharyngitis,
cervical adenitis, low-grade fever of several weeks' duration-are
common diseases in the same period of life, the first three years.
2. When a child has eczema and streptococcal fever concomi-
tantly, it is possible and likely that the skin lesions will become
endogenously infected with hemolytic streptococci. In some cases
the skin may become infected exogenously and perhaps the upper
respiratory tract may be contaminated from the skin; it is probably
not possible to determine in most ofthe cases the sequence of events;
but the important fact is clear-that infection of the upper respira-
tory tract and infection of eczematous skin in children are often
present at the same time.
3. Treatment of the skin lesions with an ointment of five
per cent sulfathiazole in white vaseline is an effective medicament.
Oral administration of a sulfonamide is not indicated in simple strep-
tococcal fever with simple infection of the eczematous lesions.
However, a sulfonamide should be given orally if there is bac-
teremia, erysipelas, progressing adenopathy, or internal streptococcal
localization.
4. The sulfonamide treatment of infected eczema is in addition
to and not in lieu of the usual procedures carried out in cases of
atopic dermatitis; control of infection does not cure eczema but does
markedly facilitate its care and promote a favorable course.
5. In this series of 48 cases of infected eczema (38 treated with
sulfonamides) febrile reactions to the drugs were occasionally
observed but no incidents of sensitivity to re-administration were
recognized. Our experience in this respect may be favorably con-
ditioned by the fact that our patients are, for the most part, young
children.
6. In this series, ointment was applied in the average case for
a week or ten days; endogenous re-infection is possibly occurring
often; we were unable to detect any harmful effects of too prolonged
exhibition of sulfonamides.
7. The physician will have to decide in the individual case
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whether or not the danger of inducing a sulfonamide sensitivity and
thus prohibiting subsequent use of the drug seems greater than the
benefit derived from treatment of the condition at hand. Fear of
developing sensitivity probably rules out prophylactic use of oint-
ment in cases of uninfected eczema in patients with streptococcal
fever.
REFERENCES
I Boisvert, P. L.: Diagnosis of streptococcosis in children. Am. J. Dis. Child.,
1942, 64, 505-15.
2 Boisvert, P. L., Darrow, D. C., Powers, G. F., and Trask, J. D.: Streptococ-
cosis in children. Am. J. Dis. Child., 1942, 64, 516-34.
3 Cohen, M. H., Thomas, H. B., and Kalisch, A. C.: Hypersensitivity produced
by the topical application of sulfathiazole. J. Am. Med. Asso., 1943,
121, 408-11.
4 Cole, H. N.: The local use of sulfonamide compounds in dermatology.
J. Am. Med. Asso., 1943, 123, 411-17.
5 Colebrook, L., Maxted, W. R., and Johns, A. M.: The presence of haemolytic
and other streptococci on human skin. J. Path. & Bact., 1935, 41,
521-27.
6 Green, R. C., Steckel, M. L., and Michener, J. M.: A different concept of
reactions following sulfathiazole readministration. Mil. Surgeon, 1943,
93, 399-405.
7 Higgins, N. R.: Hemolytic Streptococci from Common Skin Lesions of Chil-
dren. 1941, Thesis, Yale Univ. Sch. of Med.
8 Keefer, C. S.: Hemolytic streptococcus infections-Their importance in acute
and chronic disease. Rocky Mountain Med. J., 1941, 38, 789-94.
9 Keeney, E. L., Pembroke, R. H., Chatard, F. E., and Ziegler, J. M.: Sulfa-
thiazole ointment in the treatment of cutaneous infections. J. Am. Med.
Asso., 1941, 117, 1415-17.
10 Lancefield, R. C.: The Harvey Lectures: Specific Relationship of Cell Compo-
sition to Biological Activity of Hemolytic Streptococci. Lancaster, The
Science Press Printing Co., 1941.
11 Livingood, C. S., and Pillsbury, D. M.: Sulfathiazole in eczematous pyoderma:
Sensitization reaction to successive local and oral therapy. J. Am. Med.
Asso., 1943, 121, 406-8.
12 Lyons, R. JH., and Balberor, H.: Febrile reactions accompanying the read-
ministration of sulfathiazole. J. Am. Med. Asso., 1942, 118, 955-58.
13 Powers, G. F., and Boisvert, P. L.: Tuberculosis and streptococcosis. Yale J.
Biol. & Med., 1943, 15, 517-30.
14 Rantz, L. A., and Keefer, C. S.: The distribution of hemolytic streptococci
Groups A, B, and C, in human infections. J. Infect. Dis., 1941, 68,
128-32.
15 Spink, W. W.: Sulfanilamide and Related Compounds in General Practice.
Chicago, The Year Book P-ablishers, Inc., 1943.612 YALE JOURNAL OF BIOLOGY AND MEDICINE
16 Strakosch, E. A., and Clark, W. G.: Studies on the Penetration of Sulfonamides
into the Skin. Am. J. Med. Sci., 1943, 205, 518-24.
Strakosch, E. A., and Olsen, V. M.: Bacteriostatic effect of sulfathiazole in
various ointment bases. Arch. Dermat. & Syph., 1942, 46, 44-53.
17 Weiner, A. L.: Cutaneous hypersensitivity to topical application of sulfathiazole.
J. Am. Med. Asso., 1943, 121, 411-13.
18 Wenner, H. A.: Complications of infantile eczema caused by herpes simplex
virus. Am. J. Dis. Child., 1944 (In press).